{"id":"W3010644992","doi":"10.1200/jco.2013.31.15_suppl.4504","title":"Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sunitinib; Hazard ratio; Everolimus; Progression-free survival; Internal medicine; Surgery; Renal cell carcinoma; Confidence interval; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00181939,0.001679105,0.00270636,0.0003753567,0.0005130493,0.001189351,0.001216529,0.001534255,0.01278453],"category_scores_gemma":[0.001713229,0.000689577,0.002015354,0.0004220637,0.0009005895,0.001197785,0.0004617753,0.003467038,0.001664656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001007706,"about_ca_system_score_gemma":0.001755639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001117277,"about_ca_topic_score_gemma":0.003577526,"domain_scores_codex":[0.9995541,0.0002358866,0.000029414,0.00007927705,0.00003510022,0.00006608121],"domain_scores_gemma":[0.9990343,0.0002563224,0.0002761669,0.0000771739,0.00004608581,0.0003100229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9803139,0.006440042,0.00048914,0.0006391784,0.0007702569,0.00002486823,0.00003873732,0.0003331873,0.001575177,0.00009900114,0.001076372,0.008200113],"study_design_scores_gemma":[0.9573266,0.04049061,0.0007922139,0.00001920105,0.0003089998,0.00003149902,0.00001184227,0.0002216815,0.0001939071,0.00008518877,0.0005107991,0.000007413701],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9777961,0.004811148,0.0009273973,0.001008591,0.0007605056,0.006867104,0.004198768,0.000287411,0.00334301],"genre_scores_gemma":[0.9736821,0.003005677,0.002030249,0.001761464,0.0006549081,0.007721268,0.004862962,0.00005992362,0.006221618],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01278453,"threshold_uncertainty_score":0.04276854,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1161216807402814,"score_gpt":0.3856444908119123,"score_spread":0.2695228100716308,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}